Amlodipine Basilate and Cancer: Meta-Analytical Evidence on Risk Association in Hypertension Treatment
Abstract
Amlodipine Basilate is widely prescribed for the management of hypertension. However, concerns have emerged regarding its long-term safety, particularly its potential association with cancer risk. This study aims to evaluate the relationship between prolonged use of Amlodipine Basilate and the incidence of cancer through a systematic review and meta-analysis of existing literature. This meta-analysis followed the PRISMA guidelines. A comprehensive literature search was conducted using Google Scholar and PubMed databases to identify relevant studies assessing cancer risk associated with Amlodipine Basilate. Eligible studies were selected based on predefined inclusion criteria, and data were extracted for analysis. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. Fixed-effect and random-effect models were applied based on the level of heterogeneity, which was assessed using the Q statistic and I² index. Publication bias was evaluated through funnel plot analysis. Out of 321,438 studies initially identified, 30 met the inclusion criteria and were included in the final analysis. The pooled results demonstrated a statistically significant increase in cancer risk among users of Amlodipine Basilate (Z = 86.147, p < 0.0001). Several individual studies reported odds ratios above 1.2, indicating elevated risk. The heterogeneity among studies was substantial (Q = 134.56, I² = 79.2%), warranting the use of a random-effects model. Funnel plot analysis showed no significant publication bias, supporting the reliability of the findings. The findings suggest a significant association between prolonged use of Amlodipine Basilate and increased cancer risk. While these results highlight the need for cautious long-term use of the drug, they do not establish causality. Further large-scale, longitudinal studies are recommended to clarify the mechanisms involved and confirm these associations.
Keywords
Amlodipine Basilate, Hypertension, Cancer Risk, Meta-analysis, Systematic Review, Odds Ratio, Publication Bias
Citations
IRE Journals:
Audi, Najib Isyaku , Adehi, Mary Unekwu , Nweze, Nweaze Obini , Maijama’a, Bilkisu
"Amlodipine Basilate and Cancer: Meta-Analytical Evidence on Risk Association in Hypertension Treatment" Iconic Research And Engineering Journals Volume 9 Issue 3 2025 Page 68-76
IEEE:
Audi, Najib Isyaku , Adehi, Mary Unekwu , Nweze, Nweaze Obini , Maijama’a, Bilkisu
"Amlodipine Basilate and Cancer: Meta-Analytical Evidence on Risk Association in Hypertension Treatment" Iconic Research And Engineering Journals, 9(3)
About IRE Journals
IRE Journals is an open access online journals established with an aim to publish high quality of research work in various diciplines. We have more than 6 years in publications. Over 2500+ papers already published.
Important Links
For Authors
Volume 9:
Issue 1Volume 8:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 7:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 6:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 5:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 4:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 3:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12